Hemoglobin levels triggering erythropoiesis-stimulating agent therapy in patients with cancer: the shift after United States Food and Drug Administration policy changes.
about
Hemoglobin levels triggering erythropoiesis-stimulating agent therapy in patients with cancer: the shift after United States Food and Drug Administration policy changes.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Hemoglobin levels triggering e ...... Administration policy changes.
@en
Hemoglobin levels triggering e ...... Administration policy changes.
@nl
type
label
Hemoglobin levels triggering e ...... Administration policy changes.
@en
Hemoglobin levels triggering e ...... Administration policy changes.
@nl
prefLabel
Hemoglobin levels triggering e ...... Administration policy changes.
@en
Hemoglobin levels triggering e ...... Administration policy changes.
@nl
P2093
P2860
P356
P1433
P1476
Hemoglobin levels triggering e ...... Administration policy changes.
@en
P2093
Denise M Hynes
Elizabeth Tarlov
Howard Ozer
Kevin T Stroupe
Laura C Michaelis
Margaret M Browning
Qiuying L Zhang
Ramon Durazo-Arvizu
Thomas W Weichle
P2860
P304
P356
10.1002/PHAR.1134
P407
P50
P577
2012-10-26T00:00:00Z